TY - JOUR
T1 - Advanced imaging and artificial intelligence for Barrett's esophagus
T2 - What we should and soon will do
AU - Spadaccini, Marco
AU - Vespa, Edoardo
AU - Maselli, Roberta
AU - Fugazza, Alessandro
AU - Carrara, Silvia
AU - Anderloni, Andrea
AU - Franchellucci, Gianluca
AU - De Marco, Alessandro
AU - Repici, Alessandro
AU - Chandrasekar, Viveksandeep Thoguluva
AU - Desai, Madhav
AU - Sharma, Prateek
AU - Patel, Harsh K.
AU - Hassan, Cesare
AU - Bhandari, Pradeep
N1 - Publisher Copyright:
© 2022 Baishideng Publishing Group Co., Limited. All rights reserved.
PY - 2022/3/21
Y1 - 2022/3/21
N2 - Barrett's esophagus (BE) is a well-established risk factor for esophageal adenocarcinoma. It is recommended that patients have regular endoscopic surveillance, with the ultimate goal of detecting early-stage neoplastic lesions before they can progress to invasive carcinoma. Detection of both dysplasia or early adenocarcinoma permits curative endoscopic treatments, and with this aim, thorough endoscopic assessment is crucial and improves outcomes. The burden of missed neoplasia in BE is still far from being negligible, likely due to inappropriate endoscopic surveillance. Over the last two decades, advanced imaging techniques, moving from traditional dye-spray chromoendoscopy to more practical virtual chromoendoscopy technologies, have been introduced with the aim to enhance neoplasia detection in BE. As witnessed in other fields, artificial intelligence (AI) has revolutionized the field of diagnostic endoscopy and is set to cover a pivotal role in BE as well. The aim of this commentary is to comprehensively summarize present evidence, recent research advances, and future perspectives regarding advanced imaging technology and AI in BE; the combination of computer-aided diagnosis to a widespread adoption of advanced imaging technologies is eagerly awaited. It will also provide a useful step-by-step approach for performing high-quality endoscopy in BE, in order to increase the diagnostic yield of endoscopy in clinical practice.
AB - Barrett's esophagus (BE) is a well-established risk factor for esophageal adenocarcinoma. It is recommended that patients have regular endoscopic surveillance, with the ultimate goal of detecting early-stage neoplastic lesions before they can progress to invasive carcinoma. Detection of both dysplasia or early adenocarcinoma permits curative endoscopic treatments, and with this aim, thorough endoscopic assessment is crucial and improves outcomes. The burden of missed neoplasia in BE is still far from being negligible, likely due to inappropriate endoscopic surveillance. Over the last two decades, advanced imaging techniques, moving from traditional dye-spray chromoendoscopy to more practical virtual chromoendoscopy technologies, have been introduced with the aim to enhance neoplasia detection in BE. As witnessed in other fields, artificial intelligence (AI) has revolutionized the field of diagnostic endoscopy and is set to cover a pivotal role in BE as well. The aim of this commentary is to comprehensively summarize present evidence, recent research advances, and future perspectives regarding advanced imaging technology and AI in BE; the combination of computer-aided diagnosis to a widespread adoption of advanced imaging technologies is eagerly awaited. It will also provide a useful step-by-step approach for performing high-quality endoscopy in BE, in order to increase the diagnostic yield of endoscopy in clinical practice.
KW - Advanced imaging
KW - Artificial intelligence
KW - Barrett's esophagus
KW - Endoscopy
KW - Neoplasia
KW - Surveillance
UR - http://www.scopus.com/inward/record.url?scp=85127399856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127399856&partnerID=8YFLogxK
U2 - 10.3748/wjg.v28.i11.1113
DO - 10.3748/wjg.v28.i11.1113
M3 - Review article
C2 - 35431503
AN - SCOPUS:85127399856
SN - 1007-9327
VL - 28
SP - 1113
EP - 1122
JO - World journal of gastroenterology
JF - World journal of gastroenterology
IS - 11
ER -